Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cerus Corporation - Common Stock
(NQ:
CERS
)
1.230
-0.030 (-2.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cerus Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Cerus Corporation Announces Multi-Year Contract for the INTERCEPT Blood System for Platelets with the American Red Cross
April 25, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022
April 21, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Participate at the Cowen 42nd Annual Health Care Conference
February 25, 2022
From
Cerus Corporation
Via
Business Wire
Cerus's Return On Capital Employed Overview
February 23, 2022
According to data from Benzinga Pro, during Q4, Cerus's (NASDAQ:CERS) reported sales totaled $39.87 million. Despite a 26.66% increase in earnings, the company posted a loss of $9...
Via
Benzinga
Recap: Cerus Q4 Earnings
February 22, 2022
Cerus (NASDAQ:CERS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Cerus beat...
Via
Benzinga
Earnings Scheduled For February 22, 2022
February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...
Via
Benzinga
Cerus Reports Narrower Quarterly Loss As INTERCEPT Platelet Kits Lift Q4 Sales
February 23, 2022
Cerus Corp's (NASDAQ: CERS) Q4 FY21 product revenue was $39.9 million, compared to $28.2 million, driven by increased sales of INTERCEPT platelet kits to blood...
Via
Benzinga
Cerus Corporation Announces Record Fourth Quarter and Full-Year 2021 Financial Results
February 22, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Release Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022
February 08, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Participate in Upcoming Virtual Investor Conferences
February 07, 2022
From
Cerus Corporation
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
January 20, 2022
Gainers TCR2 Therapeutics (NASDAQ:TCRR) s...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 18, 2022
Gainers DBV Technologies (NASDAQ:DBVT) sh...
Via
Benzinga
Cerus Corporation Announces Record Preliminary Fourth Quarter and Full-Year 2021 Product Revenue and Provides Business Update
January 10, 2022
From
Cerus Corporation
Via
Business Wire
Uncertain Times
December 15, 2021
The UK inflation rate last month was 5.1%, not a good omen.
Via
Talk Markets
Cerus Corporation to Participate in Stephens Annual Investment Conference
November 19, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Participate in Stifel 2021 Virtual Healthcare Conference
November 08, 2021
From
Cerus Corporation
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 03, 2021
Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at...
Via
Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...
Via
Benzinga
Topics
Retirement
86 Biggest Movers From Yesterday
November 04, 2021
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million....
Via
Benzinga
Cerus Posts Lower Than Expected Q3 Loss; Raises FY21 Sales Guidance
November 03, 2021
Cerus Corporation (NASDAQ: CERS) reported Q3 sales of $42.1 million, +44% Y/Y, beating the consensus of $37.27 million. Product revenue reached $36.13 million, +53%,...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 03, 2021
Good morning, trader! We're starting the day off right with a dive into the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
25 Stocks Moving in Wednesday's Pre-Market Session
November 03, 2021
Gainers Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 56.4% to $26.20 in pre-market trading on the heels of three new announcements from the company outlining strategic plans to...
Via
Benzinga
Cerus Corporation (CERS) Q3 2021 Earnings Call Transcript
November 03, 2021
CERS earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Cerus Corporation Announces Record Third Quarter 2021 Financial Results and Raises Full-Year Product Revenue Guidance
November 02, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Release Third Quarter 2021 Financial Results on November 2, 2021
October 19, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Applauds FDA Requirements Effective Today to Safeguard the U.S. Platelet Supply
October 01, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021
September 20, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Present at the 2021 Cantor Global Virtual Healthcare Conference
September 15, 2021
From
Cerus Corporation
Via
Business Wire
Delta Variant Fears Continue
September 09, 2021
The jobless level fell to 310,000 whereas the consensus forecast was for 335,000, so risks of inflation are higher.
Via
Talk Markets
Cerus Corporation Announces CMS Issuance of P-Codes for Hospital Outpatient Billing of INTERCEPT-Based Therapeutic Products
August 10, 2021
From
Cerus Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.